China Biotech Services Holdings Limited (HKG:8037)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.730
+0.030 (4.29%)
Mar 9, 2026, 4:08 PM HKT
62.22%
Market Cap 712.28M
Revenue (ttm) 76.93M
Net Income (ttm) -150.24M
Shares Out 975.73M
EPS (ttm) -0.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 275,000
Average Volume 395,140
Open 0.710
Previous Close 0.700
Day's Range 0.700 - 0.730
52-Week Range 0.340 - 1.330
Beta -0.82
RSI 41.01
Earnings Date Mar 27, 2026

About HKG:8037

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron n... [Read more]

Sector Healthcare
Founded 1996
Employees 133
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8037
Full Company Profile

Financial Performance

In 2024, HKG:8037's revenue was 70.51 million, a decrease of -66.74% compared to the previous year's 211.99 million. Losses were -198.15 million, 107.6% more than in 2023.

Financial Statements

News

There is no news available yet.